South & Central America Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

Description

List of Tables

The South & Central America acne medication market was valued at US$ 525.48 million in 2022 and is expected to reach US$ 674.29 million by 2030; it is estimated to register at a CAGR of 3.2% from 2023 to 2030.

Upsurge in Need for Organic and Natural Treatments Fuels South & Central America Acne Medication Market

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MADARA, an organic skincare business, introduced two new and natural everyday skincare products-a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients-Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Mate tea extracts-which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the South & Central America acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the South & Central America acne medication market is expected to experience new growth trends in the coming years.

South & Central America Acne Medication Market Overview

The South & Central America acne medication market is segmented into Argentina, Brazil, Chile, and the Rest of South & Central America. The increased prevalence of acne, influenced by factors such as lifestyle changes, pollution, and stress, is driving the demand for effective acne medications that can provide quick and long-lasting results. Rise in investments and resources allocated to dermatological care, including product development activities and the promotion of effective acne medications. This financial boost enhances research and development efforts, fostering the introduction of advanced formulations and treatment options in the Brazilian market. The improved accessibility to healthcare services and growing skincare awareness further bolsters the demand for acne medications.

South & Central America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Acne Medication Market Segmentation

The South & Central America acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the South & Central America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the South & Central America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the South & Central America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the South & Central America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the South & Central America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the South & Central America acne medication market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the South & Central America acne medication market.

Product Code: BMIRE00030660

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Acne Medication Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment

5. South & Central America Acne Medication Market - Key Market Dynamics

5.1 South & Central America Acne Medication Market - Key Market Dynamics
5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - South & Central America Market Analysis

7. South & Central America Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Acne Medication Market Analysis - by Formulation

8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Acne Medication Market Analysis - by Type

9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: South & Central America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. South & Central America Acne Medication Market - Country Analysis

12.1 South & Central America
- 12.1.1 South & Central America: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Brazil
  - 12.1.1.2 Brazil: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.2.1 Brazil: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.2.2 Brazil: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.2.3 Brazil: Acne Medication Market Breakdown, by Type
    - 12.1.1.2.4 Brazil: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.2.5 Brazil: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.3 Argentina
  - 12.1.1.4 Argentina: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.4.1 Argentina: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.4.2 Argentina: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.4.3 Argentina: Acne Medication Market Breakdown, by Type
    - 12.1.1.4.4 Argentina: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.4.5 Argentina: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.5 Rest of South & Central America
  - 12.1.1.6 Rest of South & Central America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.6.1 Rest of South & Central America: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.6.2 Rest of South & Central America: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.6.3 Rest of South & Central America: Acne Medication Market Breakdown, by Type
    - 12.1.1.6.4 Rest of South & Central America: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.6.5 Rest of South & Central America: Acne Medication Market Breakdown, by Distribution Channel

13. South & Central America Acne Medication Market- Industry Landscape

13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Almirall SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bausch Health Companies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Galderma SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 GSK Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms